STUDY OBJECTIVES: To empirically derive and evaluate potential clusters of Insomnia Disorder through cluster analysis from polysomnography (PSG). We hypothesized that clusters would differ on neurocognitive performance, sleep-onset measures of quantitative (q)-EEG and heart rate variability (HRV). METHODS: Research volunteers with Insomnia Disorder (DSM-5) completed a neurocognitive assessment and overnight PSG measures of total sleep time (TST), wake time after sleep onset (WASO), and sleep onset latency (SOL) were used to determine clusters. RESULTS: From 96 volunteers with Insomnia Disorder, cluster analysis derived at least two clusters from objective sleep parameters: Insomnia with normal objective sleep duration (I-NSD: n = 53) and Insomnia with short sleep duration (I-SSD: n = 43). At sleep onset, differences in HRV between I-NSD and I-SSD clusters suggest attenuated parasympathetic activity in I-SSD (P < 0.05). Preliminary work suggested three clusters by retaining the I-NSD and splitting the I-SSD cluster into two: I-SSD A (n = 29): defined by high WASO and I-SSD B (n = 14): a second I-SSD cluster with high SOL and medium WASO. The I-SSD B cluster performed worse than I-SSD A and I-NSD for sustained attention (P ≤ 0.05). In an exploratory analysis, q-EEG revealed reduced spectral power also in I-SSD B before (Delta, Alpha, Beta-1) and after sleep-onset (Beta-2) compared to I-SSD A and I-NSD (P ≤ 0.05). CONCLUSIONS: Two insomnia clusters derived from cluster analysis differ in sleep onset HRV. Preliminary data suggest evidence for three clusters in insomnia with differences for sustained attention and sleep-onset q-EEG. CLINICAL TRIAL REGISTRATION: Insomnia 100 sleep study: Australia New Zealand Clinical Trials Registry (ANZCTR) identification number 12612000049875. URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=347742.
STUDY OBJECTIVES: To empirically derive and evaluate potential clusters of Insomnia Disorder through cluster analysis from polysomnography (PSG). We hypothesized that clusters would differ on neurocognitive performance, sleep-onset measures of quantitative (q)-EEG and heart rate variability (HRV). METHODS: Research volunteers with Insomnia Disorder (DSM-5) completed a neurocognitive assessment and overnight PSG measures of total sleep time (TST), wake time after sleep onset (WASO), and sleep onset latency (SOL) were used to determine clusters. RESULTS: From 96 volunteers with Insomnia Disorder, cluster analysis derived at least two clusters from objective sleep parameters: Insomnia with normal objective sleep duration (I-NSD: n = 53) and Insomnia with short sleep duration (I-SSD: n = 43). At sleep onset, differences in HRV between I-NSD and I-SSD clusters suggest attenuated parasympathetic activity in I-SSD (P < 0.05). Preliminary work suggested three clusters by retaining the I-NSD and splitting the I-SSD cluster into two: I-SSD A (n = 29): defined by high WASO and I-SSD B (n = 14): a second I-SSD cluster with high SOL and medium WASO. The I-SSD B cluster performed worse than I-SSD A and I-NSD for sustained attention (P ≤ 0.05). In an exploratory analysis, q-EEG revealed reduced spectral power also in I-SSD B before (Delta, Alpha, Beta-1) and after sleep-onset (Beta-2) compared to I-SSD A and I-NSD (P ≤ 0.05). CONCLUSIONS: Two insomnia clusters derived from cluster analysis differ in sleep onset HRV. Preliminary data suggest evidence for three clusters in insomnia with differences for sustained attention and sleep-onset q-EEG. CLINICAL TRIAL REGISTRATION: Insomnia 100 sleep study: Australia New Zealand Clinical Trials Registry (ANZCTR) identification number 12612000049875. URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=347742.
Authors: Kai Spiegelhalder; Lena Fuchs; Johannes Ladwig; Simon D Kyle; Christoph Nissen; Ulrich Voderholzer; Bernd Feige; Dieter Riemann Journal: J Sleep Res Date: 2011-03 Impact factor: 3.981
Authors: Julio Fernandez-Mendoza; Alexandros N Vgontzas; Duanping Liao; Michele L Shaffer; Antonio Vela-Bueno; Maria Basta; Edward O Bixler Journal: Hypertension Date: 2012-08-14 Impact factor: 10.190
Authors: Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno Journal: Sleep Date: 2009-04 Impact factor: 5.849
Authors: Megan R Crawford; Diana A Chirinos; Toni Iurcotta; Jack D Edinger; James K Wyatt; Rachel Manber; Jason C Ong Journal: J Clin Sleep Med Date: 2017-07-15 Impact factor: 4.062
Authors: Denise C Jarrin; Hans Ivers; Manon Lamy; Ivy Y Chen; Allison G Harvey; Charles M Morin Journal: J Sleep Res Date: 2018-03-01 Impact factor: 3.981
Authors: Julio Fernandez-Mendoza; Fan He; Kristina Puzino; Gregory Amatrudo; Susan Calhoun; Duanping Liao; Alexandros N Vgontzas; Edward Bixler Journal: Sleep Date: 2021-01-21 Impact factor: 5.849
Authors: Christopher B Miller; Colin A Espie; Delwyn J Bartlett; Nathaniel S Marshall; Christopher J Gordon; Ronald R Grunstein Journal: Sci Rep Date: 2018-04-27 Impact factor: 4.379
Authors: Julia L Chapman; Maria Comas; Camilla M Hoyos; Delwyn J Bartlett; Ronald R Grunstein; Christopher J Gordon Journal: Front Endocrinol (Lausanne) Date: 2018-07-16 Impact factor: 5.555
Authors: Ulla Anttalainen; L Grote; I Fietze; R L Riha; S Ryan; R Staats; J Hedner; T Saaresranta Journal: Sleep Breath Date: 2018-11-22 Impact factor: 2.655